The global opioid use disorder market is expected to grow from USD 1.86 billion in 2019 to USD 4.05 billion by 2027, at a CAGR of 10.23% during the forecast period 2020-2027.
The term opioid use disorder is given to the chronic condition, which is a result of prolonged, compulsive and continuous self-administration of the opioids. It is a lifelong disorder which possesses serious consequences like relapses, disability and even death. It also happens when one cannot control the desire to use opioid, reducing activities due to intake of opioids, increased tolerance, etc. The patients suffering from opioids use disorder are of both the type those are addicted to the medical as well as non-medical opioids.
This study delivers a comprehensive analysis of drugs, route of administration, distribution channel, applications and regions. The drugs segment includes buprenorphine, naltrexone and methadone. The buprenorphine segment further includes bunavail, suboxone, sublocade, zubsolv and others. The buprenorphine holds majority of the market shares. The most used drugs for opioid use disorder is branded suboxone and buprenorphine sublingual tablet. These drugs have excellent capabilities. The route of administration segment includes parental and oral. Oral segment constitutes a majority of the shares. The oral route is widely used due to the ease of the process. The distribution channel includes retail pharmacies, hospital pharmacies and online. Out of these, the hospital pharmacies constitute the majority of the shares. The hospitals witness a high number of patients visiting than other healthcare centres. Thus, majority of the sales are from the hospital pharmacies. The application segment includes moderate pain treatment and severe pain treatment. Among these, the severe pain treatment holds a majority of the shares. The severe pain treatment requires intensive care. The low awareness has resulted in the high market growth of the severe pain treatment segment. Consumers identify the issue once it gets severe, which is why most of them opt for a treatment when the pain gets unbearable.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America holds the majority of the share. The government initiative has helped the market to grow many folds in the region. The reason behind the formation of policies by the government is the opioid crisis of the U.S. and Canada.
Some of the notable players of the opioid use disorder market are Hikma Pharmaceuticals, Teva Pharmaceuticals, Titan Pharmaceuticals, Camurus, Omeros, MediciNova, Orexo, Alkermes, Indivior and others.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Opioid Use Disorder Market Analysis And Forecast, By Drug
Global Opioid Use Disorder Market Analysis And Forecast, By Route of Administration
Global Opioid Use Disorder Market Analysis And Forecast, By Distribution Channel
Global Opioid Use Disorder Market Analysis And Forecast, By Application
Global Opioid Use Disorder Market Analysis And Forecast, By Region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Drug
4.3.2. Market Attractiveness Analysis By Route of Administration
4.3.3. Market Attractiveness Analysis By Distribution Channel
4.3.4. Market Attractiveness Analysis By Application
4.3.5. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global Opioid Use Disorder Market Analysis and Forecast, By Drug
6.1. Segment Overview
6.2. Buprenorphine
6.2.1. Bunavail
6.2.2. Suboxone
6.2.3. Sublocade
6.2.4. Zubsolv
6.2.5. Others
6.3. Naltrexone
6.4. Methadone
7. Global Opioid Use Disorder Market Analysis and Forecast, By Route of Administration
7.1. Segment Overview
7.2. Parental
7.3. Oral
8. Global Opioid Use Disorder Market Analysis and Forecast, By Distribution Channel
8.1. Segment Overview
8.2. Retail Pharmacies
8.3. Hospital Pharmacies
8.4. Online
9. Global Opioid Use Disorder Market Analysis and Forecast, By Application
9.1. Segment Overview
9.2. Moderate Pain Treatment
9.3. Severe Pain Treatment
10. Global Opioid Use Disorder Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.5. South America
10.5.1. Brazil
10.6. Middle East and Africa
10.6.1. UAE
10.6.2. South Africa
11. Global Opioid Use Disorder Market-Competitive Landscape
11.1. Overview
11.2. Market Share of Key Players in Global Opioid Use Disorder Market
11.2.1. Global Company Market Share
11.2.2. North America Company Market Share
11.2.3. Europe Company Market Share
11.2.4. APAC Company Market Share
11.3. Competitive Situations and Trends
11.3.1. Product Launches and Developments
11.3.2. Partnerships, Collaborations, and Agreements
11.3.3. Mergers & Acquisitions
11.3.4. Expansions
12. Company Profiles
12.1. Hikma Pharmaceuticals
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Product Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Teva Pharmaceuticals
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Product Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Titan Pharmaceuticals
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Product Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. Camurus
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Product Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. Omeros
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Product Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. MediciNova
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Product Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. Orexo,
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Product Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. Alkermes
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Product Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Indivior
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Product Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
List of Table
1. Global Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
2. Global Buprenorphine Market, By Region, 2017–2027(USD Billion)
3. Global Naltrexone Market, By Region, 2017–2027(USD Billion)
4. Global Methadone Market, By Region, 2017–2027(USD Billion)
5. Global Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
6. Global Parental Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
7. Global Oral Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
8. Global Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
9. Global Retail Pharmacies Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
10. Global Hospital Pharmacies Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
11. Global Online Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
12. Global Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
13. Global Moderate Pain Treatment Market, By Region, 2017–2027(USD Billion)
14. Global Severe Pain Treatment Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
15. Global Opioid Use Disorder Market, By Region, 2017–2027(USD Billion)
16. Global Opioid Use Disorder Market, By North America, 2017–2027(USD Billion)
17. North America Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
18. North America Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
19. North America Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
20. North America Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
21. U.S. Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
22. U.S. Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
23. U.S. Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
24. U.S. Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
25. Canada Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
26. Canada Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
27. Canada Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
28. Canada Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
29. Mexico Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
30. Mexico Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
31. Mexico Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
32. Mexico Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
33. Europe Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
34. Europe Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
35. Europe Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
36. Europe Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
37. Germany Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
38. Germany Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
39. Germany Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
40. Germany Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
41. France Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
42. France Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
43. France Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
44. France Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
45. U.K. Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
46. U.K. Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
47. U.K. Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
48. U.K. Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
49. Italy Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
50. Italy Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
51. Italy Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
52. Italy Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
53. Spain Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
54. Spain Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
55. Spain Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
56. Spain Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
57. Asia Pacific Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
58. Asia Pacific Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
59. Asia Pacific Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
60. Asia Pacific Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
61. Japan Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
62. Japan Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
63. Japan Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
64. Japan Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
65. China Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
66. China Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
67. China Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
68. China Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
69. India Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
70. India Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
71. India Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
72. India Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
73. South America Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
74. South America Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
75. South America Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
76. South America Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
77. Brazil Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
78. Brazil Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
79. Brazil Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
80. Brazil Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
81. Middle East and Africa Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
82. Middle East and Africa Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
83. Middle East and Africa Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
84. Middle East and Africa Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
85. UAE Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
86. UAE Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
87. UAE Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
88. UAE Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
89. South Africa Opioid Use Disorder Market, By Drug, 2017–2027(USD Billion)
90. South Africa Opioid Use Disorder Market, By Route of Administration, 2017–2027(USD Billion)
91. South Africa Opioid Use Disorder Market, By Distribution Channel, 2017–2027(USD Billion)
92. South Africa Opioid Use Disorder Market, By Application, 2017–2027(USD Billion)
List of Figures
1. Global Opioid Use Disorder Market Segmentation
2. Opioid Use Disorder Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Opioid Use Disorder Market Attractiveness Analysis By Drug
9. Global Opioid Use Disorder Market Attractiveness Analysis By Route of Administration
10. Global Opioid Use Disorder Market Attractiveness Analysis By Distribution Channel
11. Global Opioid Use Disorder Market Attractiveness Analysis By Application
12. Global Opioid Use Disorder Market Attractiveness Analysis By Region
13. Global Opioid Use Disorder Market: Dynamics
14. Global Opioid Use Disorder Market Share By Drug (2019 & 2027)
15. Global Opioid Use Disorder Market Share By Route of Administration (2019 & 2027)
16. Global Opioid Use Disorder Market Share By Distribution Channel (2019 & 2027)
17. Global Opioid Use Disorder Market Share By Application (2019 & 2027)
18. Global Opioid Use Disorder Market Share by Regions (2019 & 2027)
19. Global Opioid Use Disorder Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.